The Global 5-(N,N-Dibenzylglycyl)salicylamide Market was valued at USD 31.8 Million in 2024 and is projected to reach USD 48.2 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 7.1% during the forecast period (2024–2030). This robust growth trajectory is fueled by the escalating demand for high-purity pharmaceutical intermediates, advancements in peptide synthesis technologies, and the expanding pipeline of novel therapeutic agents targeting conditions such as pain and inflammation where this compound shows significant potential.

As the pharmaceutical and life sciences industries intensify their focus on precision medicine and advanced drug discovery, the role of specialized chemical suppliers becomes increasingly critical. In this analysis, we profile the Top 10 Companies in the 5-(N,N-Dibenzylglycyl)salicylamide Market— a curated list of innovators, custom synthesis specialists, and bulk manufacturers shaping the global supply chain for this key pharmaceutical building block.

Download FREE Sample Report:
5-(N,N-Dibenzylglycyl)salicylamide Market – View in Detailed Research Report

---

🔟 1. Syntor Fine Chemicals Ltd

Headquarters: Manchester, United Kingdom
Key Offering: High-Purity 5-(N,N-Dibenzylglycyl)salicylamide (>98% Purity), Custom Peptide Synthesis

Syntor Fine Chemicals Ltd is a leading European supplier of advanced pharmaceutical intermediates, with a strong focus on peptide derivatives and complex organic molecules. The company has established a robust manufacturing platform for 5-(N,N-Dibenzylglycyl)salicylamide, catering to the stringent quality requirements of global pharmaceutical clients.

Innovation & Development Initiatives:

• Investment in continuous flow chemistry for scalable and efficient synthesis
• Development of proprietary purification techniques to achieve >99.5% purity levels
• Active collaborations with academic institutions for novel application research

---

9️⃣ 2. Capot Chemical Co., Ltd.

Headquarters: Hangzhou, Zhejiang, China
Key Offering: 5-(N,N-Dibenzylglycyl)salicylamide (97%-98% and >98% Purity Grades), API Intermediates

Capot Chemical is a major Chinese manufacturer with extensive experience in producing pharmaceutical intermediates and fine chemicals. Its significant production capacity and competitive pricing make it a key player in the Asian market, serving both domestic and international pharmaceutical companies.

Innovation & Development Initiatives:

• Expansion of GMP-compliant production facilities
• Implementation of green chemistry principles to reduce environmental impact
• Strategic focus on the development of cost-effective synthesis routes

---

8️⃣ 3. BettersynShanghaiBiotech Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Research-grade and GMP-grade 5-(N,N-Dibenzylglycyl)salicylamide, Peptide Building Blocks

BettersynShanghaiBiotech specializes in peptide synthesis and provides high-quality biochemical reagents to the global research community and pharmaceutical industry. The company’s expertise in solid-phase peptide synthesis (SPPS) positions it as a valuable supplier for advanced research applications.

Innovation & Development Initiatives:

• Focus on developing novel peptide-conjugated drug candidates
• Investment in analytical method development for impurity profiling
• Custom synthesis services for modified salicylamide derivatives

Download FREE Sample Report:
5-(N,N-Dibenzylglycyl)salicylamide Market – View in Detailed Research Report

---

7️⃣ 4. Top Pharm Chemical Group

Headquarters: Wuhan, Hubei, China
Key Offering: Pharmaceutical Intermediates, 5-(N,N-Dibenzylglycyl)salicylamide (Multiple Purity Grades)

Top Pharm Chemical Group is an integrated chemical enterprise with a strong focus on the development and manufacturing of advanced pharmaceutical intermediates. The company serves a diverse clientele, from early-stage biotech firms to established pharmaceutical giants.

Innovation & Development Initiatives:

• Vertical integration from raw materials to finished intermediates
• Quality control systems compliant with international regulatory standards
• Strategic partnerships with drug discovery companies for co-development

---

6️⃣ 5. CMX ALLIANCE

Headquarters: Hyderabad, Telangana, India
Key Offering: Custom Synthesis of 5-(N,N-Dibenzylglycyl)salicylamide, Contract Manufacturing

CMX ALLIANCE leverages India’s strong chemical manufacturing base to provide cost-effective and high-quality chemical synthesis services. The company’s expertise in process optimization makes it a preferred partner for pharmaceutical companies seeking scalable and economically viable production routes.

Innovation & Development Initiatives:

• Process development for large-scale manufacturing
• Focus on reducing the cost of goods for pharmaceutical clients
• Strong regulatory support for drug master file (DMF) submissions

---

5️⃣ 6. Opulent Pharma

Headquarters: Mumbai, Maharashtra, India
Key Offering: GMP-grade 5-(N,N-Dibenzylglycyl)salicylamide, Active Pharmaceutical Ingredients (APIs)

Opulent Pharma specializes in the manufacturing of APIs and advanced intermediates under strict quality control systems. The company’s focus on regulatory compliance and documentation support makes it a reliable partner for pharmaceutical companies navigating complex approval processes.

Innovation & Development Initiatives:

• Investment in state-of-the-art analytical instrumentation
• Development of intellectual property around novel synthesis pathways
• Expansion of capabilities to support clinical trial material supply

---

4️⃣ 7. NINGBO INNO PHARMCHEM CO., LTD.

Headquarters: Ningbo, Zhejiang, China
Key Offering: 5-(N,N-Dibenzylglycyl)salicylamide, Fine Chemicals and Custom Intermediates

NINGBO INNO PHARMCHEM is a rapidly growing chemical supplier with a strong export-oriented business model. The company’s strategic location in one of China’s major chemical hubs provides it with logistical advantages for global distribution.

Innovation & Development Initiatives:

• Rapid scale-up capabilities from laboratory to commercial quantities
• Focus on supply chain resilience and inventory management
• Investment in customer-centric technical support services

Download FREE Sample Report:
5-(N,N-Dibenzylglycyl)salicylamide Market – View in Detailed Research Report

---

3️⃣ 8. Firmus Laboratories Private Limited

Headquarters: Chennai, Tamil Nadu, India
Key Offering: High-Purity Chemical Intermediates, 5-(N,N-Dibenzylglycyl)salicylamide for R&D

Firmus Laboratories is an Indian company with a strong research and development focus. It serves both the domestic pharmaceutical market and international clients with a portfolio of specialty chemicals and intermediates tailored for drug discovery and development.

Innovation & Development Initiatives:

• Collaborative research projects with academic institutions
• Development of proprietary analytical methods for quality assurance
• Focus on niche, high-value pharmaceutical intermediates

---

2️⃣ 9. Baoji Guokang Bio-Technology Co., Ltd

Headquarters: Baoji, Shaanxi, China
Key Offering: Bio-based Chemical Intermediates, 5-(N,N-Dibenzylglycyl)salicylamide

Baoji Guokang Bio-Technology combines expertise in traditional chemical synthesis with an emerging focus on bio-catalytic processes. The company is exploring more sustainable production methods for complex molecules like 5-(N,N-Dibenzylglycyl)salicylamide.

Innovation & Development Initiatives:

• Research into enzymatic synthesis pathways
• Exploration of green chemistry alternatives for hazardous reagents
• Development of chiral synthesis capabilities for related compounds

---

1️⃣ 10. Ami Organics Limited

Headquarters: Surat, Gujarat, India
Key Offering: Advanced Pharmaceutical Intermediates, Custom Synthesis of Complex Molecules

Ami Organics is a publicly-listed Indian company and a leading supplier of specialty chemicals to the pharmaceutical industry. With a strong R&D foundation and multiple manufacturing facilities, the company is well-positioned to serve the growing global demand for high-quality intermediates like 5-(N,N-Dibenzylglycyl)salicylamide.

Innovation & Development Initiatives:

• Significant annual investment in research and development
• Strategic acquisitions to expand technological capabilities
• Focus on developing proprietary processes for key intermediates

Get Full Report Here:
5-(N,N-Dibenzylglycyl)salicylamide Market – View in Detailed Research Report

---

🔬 Outlook: The Future of 5-(N,N-Dibenzylglycyl)salicylamide Is Driven by Innovation and Precision

The market for 5-(N,N-Dibenzylglycyl)salicylamide is at a pivotal juncture. As a key intermediate in pharmaceutical development, its demand is intricately linked to the progress of drug discovery programs exploring its therapeutic potential, particularly in areas like non-opioid pain management and anti-inflammatory applications.

📈 Key Trends Shaping the Market:

• Increasing adoption of continuous manufacturing processes for improved efficiency and consistency
• Growing emphasis on green chemistry principles to minimize environmental impact
• Rising demand for ultra-high purity grades (>99.5%) for clinical trial materials
• Expansion of contract development and manufacturing organization (CDMO) capabilities in Asia

Get Full Report Here:
5-(N,N-Dibenzylglycyl)salicylamide Market – View in Detailed Research Report

The companies profiled above are not only supplying a critical pharmaceutical building block—they are enabling the next generation of therapeutic innovations that could address significant unmet medical needs.